Arbutus CEO William Collier To Retire At The End Of 2023; Michael J. McElhaugh To Serve As Interim CEO
Portfolio Pulse from Benzinga Newsdesk
Arbutus Biopharma Corporation's CEO, William Collier, has announced his retirement at the end of 2023. Michael J. McElhaugh will serve as the interim CEO.

November 07, 2023 | 12:21 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Arbutus Biopharma Corporation (ABUS) will see a leadership change with the retirement of CEO William Collier at the end of 2023. Michael J. McElhaugh will serve as interim CEO.
CEO transitions can lead to uncertainty and volatility in a company's stock. However, the announcement is well in advance and an interim CEO has been named, which may mitigate some of the potential instability. The impact on the stock price in the short term is neutral as the market will likely wait to assess the new leadership's strategy and performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100